These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Structure-activity relationships among various retinoids and their ability to inhibit neoplastic transformation and to increase cell adhesion in the C3H/10T1/2 CL8 cell line. Bertram JS. Cancer Res; 1980 Sep; 40(9):3141-6. PubMed ID: 6448686 [Abstract] [Full Text] [Related]
3. Prevention of carcinogenesis by protease inhibitors. Kennedy AR. Cancer Res; 1994 Apr 01; 54(7 Suppl):1999s-2005s. PubMed ID: 8137328 [Abstract] [Full Text] [Related]
4. Resting state depth and saturation density as modulated by tumor promoters and culture conditions: relationship to chemical transformation in C3H/10T1/2 cells. Miska D, Bosmann HB. J Natl Cancer Inst; 1982 Feb 01; 68(2):259-66. PubMed ID: 6950158 [Abstract] [Full Text] [Related]
5. Application of retinoid stabilized carcinogen-initiated cells to the quantitation of transformation in the C3H/10T1/2 cell line. Bertram JS. Carcinog Compr Surv; 1985 Feb 01; 9():327-36. PubMed ID: 4053080 [No Abstract] [Full Text] [Related]
6. Effects of protease inhibitors on radiation transformation in vitro. Kennedy AR, Little JB. Cancer Res; 1981 Jun 01; 41(6):2103-8. PubMed ID: 7237415 [Abstract] [Full Text] [Related]
9. Recommendations for experimental protocols and for scoring transformed foci in BALB/c 3T3 and C3H 10T1/2 cell transformation. IARC Sci Publ; 1985 Jun 01; 67():205-19. PubMed ID: 3830890 [No Abstract] [Full Text] [Related]
10. Studies of tumor promoters with the Syrian hamster embryo cell transformation assay. Sanner T, Rivedal E. Carcinog Compr Surv; 1985 Jun 01; 9():167-78. PubMed ID: 4053072 [No Abstract] [Full Text] [Related]
11. Promoting effect of bile acids on the chemical transformation of C3H/10T1/2 fibroblasts in vitro. Kaibara N, Yurugi E, Koga S. Cancer Res; 1984 Dec 01; 44(12 Pt 1):5482-5. PubMed ID: 6498811 [Abstract] [Full Text] [Related]
12. Cellular epigenetics and the origin of cancer. Cuthill S. Bioessays; 1994 Jun 01; 16(6):393-4. PubMed ID: 8080428 [No Abstract] [Full Text] [Related]
13. Combined effects of tumor promoters and serum on proliferin mRNA induction: a biomarker sensitive to saccharin, 2,3,7,8-TCDD, and other compounds at minimal concentrations promoting C3H/10T1/2 cell transformation. Parfett CL. J Toxicol Environ Health A; 2003 Oct 24; 66(20):1943-66. PubMed ID: 14514435 [Abstract] [Full Text] [Related]
14. Protease inhibitors in carcinogenesis: possible sites of action. Rossman TG, Troll W. Carcinog Compr Surv; 1980 Oct 24; 5():127-43. PubMed ID: 6992994 [No Abstract] [Full Text] [Related]
15. Chemical transformation in C3H 10T1/2 Cl 8 mouse embryo fibroblasts: historical background, assessment of the transformation assay, and evolution and optimization of the transformation assay protocol. Landolph JR. IARC Sci Publ; 1985 Oct 24; 67():185-203. PubMed ID: 3913642 [No Abstract] [Full Text] [Related]
16. Quantitative neoplastic transformation of C3H/10T1/2 fibroblasts: dependence upon the size of the initiated cell colony at confluence. Mordan LJ, Martner JE, Bertram JS. Cancer Res; 1983 Sep 24; 43(9):4062-7. PubMed ID: 6871847 [Abstract] [Full Text] [Related]